# TTM Technologies Inc: Form 10-Q for the period ended Jun 29, 2026

- Company: [TTM Technologies Inc](/companies/ttmi.md) (CIK 1116942)
- Form: 10-Q
- Filed: 2026-08-05
- Accepted by EDGAR: Aug 5, 2026, 16:10 ET
- Period: 2026-06-29
- Accession: 0001193125-26-335107
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1116942/000119312526335107/ttmi-20260629.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1116942/000119312526335107/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2026-06-29.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2026-03-31 to 2026-06-29 | $1.00bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months, 2025-12-30 to 2026-06-29 | $1.85bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2026-03-31 to 2026-06-29 | $792.2m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months, 2025-12-30 to 2026-06-29 | $1.46bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2026-03-31 to 2026-06-29 | $211.9m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2025-12-30 to 2026-06-29 | $393.0m | us-gaap:GrossProfit |
| Research and development | 3 months, 2026-03-31 to 2026-06-29 | $8.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2025-12-30 to 2026-06-29 | $15.8m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2026-03-31 to 2026-06-29 | $109.1m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2025-12-30 to 2026-06-29 | $181.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2026-03-31 to 2026-06-29 | $10.5m | us-gaap:InterestExpenseNonoperating |
| Interest expense | 6 months, 2025-12-30 to 2026-06-29 | $21.1m | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months, 2026-03-31 to 2026-06-29 | −$1.8m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2025-12-30 to 2026-06-29 | $6.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2026-03-31 to 2026-06-29 | $83.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2025-12-30 to 2026-06-29 | $133.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2026-03-31 to 2026-06-29 | $0.77 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2025-12-30 to 2026-06-29 | $1.24 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2026-03-31 to 2026-06-29 | $0.80 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2025-12-30 to 2026-06-29 | $1.28 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2026-03-31 to 2026-06-29 | 107,583,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2025-12-30 to 2026-06-29 | 107,334,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2025-12-30 to 2026-06-29 | $118.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2025-12-30 to 2026-06-29 | $169.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months, 2025-12-30 to 2026-06-29 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2026-06-29 | $507.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2026-06-29 | $2.25bn | us-gaap:AssetsCurrent |
| Total assets | at 2026-06-29 | $4.42bn | us-gaap:Assets |
| Current liabilities | at 2026-06-29 | $1.26bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2026-06-29 | $969.5m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2026-06-29 | $4.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2026-06-29 | $1.93bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 27,779 characters.

### Cautionary Statement Regarding Forward-Looking Statements

*This Report contains forward-looking statements regarding future events or our future financial and operational performance. Forward-looking statements include statements regarding markets for our products; trends in net sales, gross profits, and estimated expense levels; liquidity and anticipated cash needs and availability; and any statement that contains the words “anticipate,” “believe,” “plan,” “forecast,” “foresee,” “estimate,” “project,” “expect,” “seek,” “target,” “intend,” “goal,” and other similar expressions. The forward-looking statements included in this Report reflect our current expectations and beliefs, and we do not undertake publicly to update or revise these statements, even if experience or future changes make it clear that any projected results expressed in this Report or future quarterly reports to stockholders, press releases, or company statements will not be realized. In addition, the inclusion of any statement in this Report does not constitute an admission by us that the events or circumstances described in such statement are material. Furthermore, we wish to caution and advise readers that these statements are based on assumptions that may not materialize and may involve risks and uncertainties, many of which are beyond our control, that could cause actual events or performance to differ materially from those contained or implied in these forward-looking statements. These risks and uncertainties include the risks identified under the heading "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 29, 2025, as updated by our other filings with the SEC, and described elsewhere in this Report. The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated condensed financial statements and the related notes and the other financial information included in this Report, as well as the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” set forth in our Annual Report on Form 10-K for the fiscal year ended December 29, 2025, filed with the SEC.*

### COMPANY OVERVIEW

We are a leading global manufacturer of technology products, including mission systems, RF components, RF microwave/microelectronic assemblies, and technologically advanced interconnect products, including PCBs and substrates. We focus on providing time-to-market and volume production of advanced technology products and offer a one-stop design, engineering, and manufacturing solution to our customers. This solution allows us to align technology development with the diverse needs of our customers and to enable them to reduce the time required to develop new products and bring them to market. We serve a diversified customer base consisting of approximately 1,300 customers in various markets throughout the world, including aerospace and defense; automotive; data center and networking; and medical, industrial, and instrumentation. Our customers include OEMs, EMS providers, ODMs, distributors, and government agencies (both domestic and allied foreign governments).

### RECENT DEVELOPMENTS

We previously announced we are in the process of constructing a new advanced technology PCB manufacturing facility in Syracuse, New York. We expect that our new facility will bring advanced technology capability for our domestic high-volume production of ultra‑high‑density interconnect (HDI) PCBs in support of national security requirements. The building construction is complete, equipment is arriving, and we continue to install and test equipment setups. Volume production in this facility is expected to commence in the second half of 2026.

On June 1, 2026, we entered into the 2026 Credit Agreement, which amended and restated our Prior Term Loan Facility, and provided for the Amended Term Loan Facility and a new RCF that replaced our prior revolving credit facilities, which have been terminated. In addition, the 2026 Credit Agreement will permit us to add one or more senior secured incremental term loan facilities to the Amended Term Loan Facility, subject to the satisfaction of certain conditions.

On June 17, 2026, we announced that we had entered into definitive stock purchase agreements to acquire STG and ILFA in separate transactions. These proposed transactions are expected to close in the third quarter of 2026, subject to the satisfaction of regulatory approvals and other customary closing conditions. In connection with the proposed STG acquisition, we entered into an economic hedge to mitigate foreign currency risk of the CHF-denominated purchase price and interest related to the planned drawdown under the RCF to finance the proposed STG acquisition.

### FINANCIAL OVERVIEW

Our customers include both OEMs and EMS providers. We sell to OEMs both directly and indirectly through EMS providers. For such indirect sales, we classify net sales based on OEM companies as they are the ultimate end customers. Sales to our ten largest customers collectively accounted for 55% of our net sales for both the quarter and two quarters ended June 29, 2026. Sales to our ten largest customers collectively accounted for 53% and 54% of our net sales for the quarter and two quarters ended June 30, 2025, respectively.

The percentage of our net sales attributable to each of the principal end markets we served was as follows:

| End Markets (2): | For the Quarter Ended June 29, 2026 | June 30, 2025 (1) | For the Two Quarters Ended June 29, 2026 | June 30, 2025 (1) |
| --- | ---: | ---: | ---: | ---: |
| Aerospace and Defense | 37% | 45% | 39% | 47% |
| Automotive | 8 | 11 | 8 | 11 |
| Data Center and Networking | 40 | 29 | 38 | 28 |
| Medical, Industrial, and Instrumentation | 15 | 15 | 15 | 14 |
| Total | 100% | 100% | 100% | 100% |

(1) The end market revenue for the quarter and two quarters ended June 30, 2025 has been recast to reflect the combination of the data center computing and networking end markets.

(2) Sales to EMS companies are classified by the end markets of their OEM customers.

### CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Our consolidated condensed financial statements included in this Report have been prepared in accordance with U.S. GAAP. The preparation of these consolidated condensed financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, net sales and expenses, and related disclosure of contingent assets and liabilities.

See Item 7, *Management’s Discussion and Analysis of Financial Condition and Results of Operations*, in our Annual Report on Form 10-K for the fiscal year ended December 29, 2025 for further discussion of critical accounting policies and estimates. There have been no material changes to our critical accounting policies and estimates since December 29, 2025.

### CONSOLIDATED OPERATING RESULTS

Net sales consist of gross sales less an allowance for returns, which typically have been approximately 2% of gross sales. We provide our customers a limited right of return for defective PCBs including components, assemblies, and subsystems. We record an estimate for sales returns and allowances at the time of sale based on historical results and anticipated returns.

Selected financial highlights are presented in the table below:

*(In thousands, except margin rates)*

|  | For the Quarter Ended June 29, 2026 | June 30, 2025 | For the Two Quarters Ended June 29, 2026 | June 30, 2025 |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $1,004,054 | $730,621 | $1,850,030 | $1,379,289 |
| Cost of goods sold | 792,196 | 582,512 | 1,456,991 | 1,100,208 |
| Gross profit | 211,858 | 148,109 | 393,039 | 279,081 |
| Gross margin | 21.1% | 20.3% | 21.2% | 20.2% |
| Operating expenses: |  |  |  |  |
| Selling and marketing | 25,490 | 21,316 | 50,484 | 42,587 |
| General and administrative | 62,107 | 49,719 | 130,852 | 93,493 |
| Research and development | 7,978 | 7,009 | 15,786 | 15,073 |
| Amortization of definite-lived intangibles | 6,888 | 6,888 | 13,777 | 13,777 |
| Restructuring charges | 340 | 1,408 | 636 | 2,122 |
| Total operating expenses | 102,803 | 86,340 | 211,535 | 167,052 |
| Operating income | 109,055 | 61,769 | 181,504 | 112,029 |
| Operating margin | 10.9% | 8.5% | 9.8% | 8.1% |
| Total other expense, net | (27,808) | (16,244) | (41,732) | (25,513) |
| Income tax benefit (provision) | 1,800 | (3,995) | (6,737) | (12,808) |
| Net income | $83,047 | $41,530 | $133,035 | $73,708 |

### Net Sales

Total net sales increased $273.4 million, or 37.4%, to $1,004.1 million for the quarter ended June 29, 2026, from $730.6 million for the quarter ended June 30, 2025. The primary driver of this increase was due to continued strong demand in our data center and networking end market driven by the continued build out of AI data centers and related applications, as well as strong growth in our aerospace and defense and medical, industrial, and instrumentation end markets.

Total net sales increased $470.7 million, or 34.1%, to $1,850.0 million for the two quarters ended June 29, 2026, from $1,379.3 million for the two quarters ended June 30, 2025. The primary driver of this increase was due to continued strong demand in our data center and networking end market driven by the continued build out of AI data centers and related applications, as well as strong growth in our medical, industrial, and instrumentation and aerospace and defense end markets.

### Gross Profit and Margin Rate

Gross profit increased $63.7 million to $211.9 million for the quarter ended June 29, 2026, from $148.1 million for the quarter ended June 30, 2025. Gross margin rate increased to 21.1% for the quarter ended June 29, 2026, from 20.3% for the quarter ended June 30, 2025. These increases were primarily due to higher sales volume, favorable product mix, and improved operational execution.

Gross profit increased $114.0 million to $393.0 million for the two quarters ended June 29, 2026, from $279.1 million for the two quarters ended June 30, 2025. Gross margin rate increased to 21.2% for the two quarters ended June 29, 2026, from 20.2% for the two quarters ended June 30, 2025. These increases were primarily due to higher sales volume, favorable product mix, and improved operational execution.

### Operating Expenses

Operating expenses increased $16.5 million to $102.8 million for the quarter ended June 29, 2026, from $86.3 million for the quarter ended June 30, 2025, primarily due to higher labor costs, incentive compensation, and acquisition costs.

Operating expenses increased $44.5 million to $211.5 million for the two quarters ended June 29, 2026, from $167.1 million for the two quarters ended June 30, 2025, primarily due to higher stock-based compensation, labor costs, incentive compensation, and acquisition costs. The increase in stock-based compensation was primarily driven by exceeding predetermined targets, stock price appreciation, and vesting of certain performance-based stock grants.

### Operating Income and Margin Rate

Operating income increased $47.3 million to $109.1 million for the quarter ended June 29, 2026, from $61.8 million for the quarter ended June 30, 2025. Operating margin rate increased to 10.9% for the quarter ended June 29, 2026, from 8.5% for the quarter ended June 30, 2025. The primary drivers of these increases are discussed above in the variance explanations for *Gross Profit and Margin Rate* and *Operating Expenses.*

Operating income increased $69.5 million to $181.5 million for the two quarters ended June 29, 2026, from $112.0 million for the two quarters ended June 30, 2025. Operating margin rate increased to 9.8% for the two quarters ended June 29, 2026, from 8.1% for the two quarters ended June 30, 2025. The primary drivers of these increases are discussed above in the variance explanations for *Gross Profit and Margin Rate* and *Operating Expenses.*

### Total Other Expense, Net

Total other expense, net increased $11.6 million to $27.8 million for the quarter ended June 29, 2026, from $16.2 million for the quarter ended June 30, 2025, primarily due to a higher amount of foreign exchange losses during the quarter ended June 29, 2026 resulting from strengthening RMB and MYR during the quarter ended June 29, 2026 as compared to the quarter ended June 30, 2025. We utilize the RMB and MYR at our China and Malaysia facilities, respectively, for employee‑related and other costs of running our operations in foreign countries.

Total other expense, net increased $16.2 million to $41.7 million for the two quarters ended June 29, 2026, from $25.5 million for the two quarters ended June 30, 2025, primarily due to a higher amount of foreign exchange losses during the two quarters ended June 29, 2026 resulting from strengthening RMB and MYR during the two quarters ended June 29, 2026 as compared to the two quarters ended June 30, 2025.

### Income Taxes

Income tax benefit increased $5.8 million to $1.8 million for the quarter ended June 29, 2026, from $4.0 million income tax expense for the quarter ended June 30, 2025, primarily due to tax benefits from the deduction of stock-based compensation, partially offset by tax expense driven by higher income before income taxes.

Income tax expense decreased $6.1 million to $6.7 million for the two quarters ended June 29, 2026, from $12.8 million for the two quarters ended June 30, 2025, primarily due to tax benefits from the deduction of stock-based compensation, partially offset by tax expense driven by higher income before income taxes.

Our effective tax rate is primarily impacted by the mix of foreign and U.S. income, tax rates in China and Hong Kong, the U.S. federal income tax rate, apportioned state income tax rates, the generation of credits and deductions available to us as well as changes in valuation allowances and certain non-deductible items. We had a net deferred income tax liability of $52.8 million and $41.8 million as of June 29, 2026 and June 30, 2025, respectively.

### SEGMENT OPERATING RESULTS

### Basis of Presentation

During the quarter ended March 30, 2026, the Company strategically realigned RF&S Components within the A&D sector and concluded that the Company now has two reportable segments: A&D and Commercial. In prior periods, the Company had three reportable segments: A&D, Commercial, and RF&S Components following a change during the quarter ended June 30, 2025. As a result, certain prior period amounts have been reclassified to conform with this new presentation. See Part I, Item 1, Note 4, *Segment Information*, of the Notes to Consolidated Condensed Financial Statements in this Report for further information.

Selected segment financial highlights, with reconciliations to operating income, are presented in the table below:

*(In thousands, except margin rates)*

| Segment sales: | For the Quarter Ended June 29, 2026 | June 30, 2025 | For the Two Quarters Ended June 29, 2026 | June 30, 2025 |
| --- | ---: | ---: | ---: | ---: |
| A&D | $382,750 | $335,183 | $734,414 | $651,433 |
| Commercial | 621,605 | 395,624 | 1,116,648 | 728,329 |
| Total | $1,004,355 | $730,807 | $1,851,062 | $1,379,762 |
| Segment operating income: |  |  |  |  |
| A&D | $63,861 | $48,145 | $118,640 | $90,514 |
| Commercial | 112,676 | 60,069 | 194,244 | 103,718 |
| Total | 176,537 | 108,214 | 312,884 | 194,232 |
| Segment operating margin rate: |  |  |  |  |
| A&D | 16.7% | 14.4% | 16.2% | 13.9% |
| Commercial | 18.1% | 15.2% | 17.4% | 14.2% |
| Total | 17.6% | 14.8% | 16.9% | 14.1% |
| Unallocated amounts: |  |  |  |  |
| Restructuring | (340) | (1,408) | (636) | (2,122) |
| Acquisition-related and other charges | (4,749) | — | (4,946) | — |
| Stock-based compensation | (13,292) | (9,188) | (37,648) | (17,975) |
| Other corporate expenses | (39,877) | (26,625) | (69,702) | (43,658) |
| Amortization of definite-lived intangibles (1) | (9,224) | (9,224) | (18,448) | (18,448) |
| Operating income | $109,055 | $61,769 | $181,504 | $112,029 |

(1) Amortization of definite-lived intangibles relates to the A&D reportable segment, but is not reviewed separately by the CODM.

Segment operating income, as reconciled in Part I, Item 1, Note 4, *Segment Information*, of the Notes to Consolidated Condensed Financial Statements in this Report, and segment operating margin rate (segment operating income divided by segment sales) are presented in conformity with Accounting Standards Codification (ASC) Topic 280, *Segment Reporting*. These measures are reported to the CODM, who is the President and CEO, for purposes of making decisions about allocating resources to the segments and assessing their performance. For these reasons, these measures are excluded from the definition of non‑GAAP financial measures under the SEC's Regulation G and Item 10(e) of Regulation S-K.

### A&D

### Segment Sales

Segment sales for the A&D reportable segment increased $47.6 million, or 14.2%, to $382.8 million for the quarter ended June 29, 2026, from $335.2 million for the quarter ended June 30, 2025. The primary drivers of this increase were strong defense budget spending, our strong strategic program alignment, and key bookings for ongoing franchise programs, including restricted programs. These increases were driven by increased sales related to missiles and munitions as well as strong demand in our mission systems and specialty assembly businesses.

Segment sales for the A&D reportable segment increased $83.0 million, or 12.7%, to $734.4 million for the two quarters ended June 29, 2026, from $651.4 million for the two quarters ended June 30, 2025. The primary drivers of the increase were as discussed in the paragraph above.

### Segment Operating Income and Margin Rate

Segment operating income for the A&D reportable segment increased $15.7 million to $63.9 million for the quarter ended June 29, 2026, from $48.1 million for the quarter ended June 30, 2025. Segment operating margin rate for the A&D reportable segment increased to 16.7% for the quarter ended June 29, 2026, from 14.4% for the quarter ended June 30, 2025. The primary drivers of these increases were higher sales volume, as discussed above, favorable product mix, and improved operational execution.

Segment operating income for the A&D reportable segment increased $28.1 million to $118.6 million for the two quarters ended June 29, 2026, from $90.5 million for the two quarters ended June 30, 2025. Segment operating margin rate for the A&D reportable segment increased to 16.2% for the two quarters ended June 29, 2026, from 13.9% for the two quarters ended June 30, 2025. The primary drivers of these increases were as discussed in the paragraph above.

### Commercial

### Segment Sales

Segment sales for the Commercial reportable segment increased $226.0 million, or 57.1%, to $621.6 million for the quarter ended June 29, 2026, from $395.6 million for the quarter ended June 30, 2025. The primary drivers of this increase were strong demand in our data center and networking end market driven by the continued buildout of AI data centers and related applications, as well as strong sales performance in our medical, industrial, and instrumentation end market.

Segment sales for the Commercial reportable segment increased $388.3 million, or 53.3%, to $1,116.6 million for the two quarters ended June 29, 2026, from $728.3 million for the two quarters ended June 30, 2025. The primary drivers of this increase were as discussed in the paragraph above.

### Segment Operating Income and Margin Rate

Segment operating income for the Commercial reportable segment increased $52.6 million to $112.7 million for the quarter ended June 29, 2026, from $60.1 million for the quarter ended June 30, 2025. Segment operating margin rate for the Commercial reportable segment increased to 18.1% for the quarter ended June 29, 2026, from 15.2% for the quarter ended June 30, 2025. The primary drivers of these increases were higher sales volume, as discussed above, improving mix, and improved operational execution.

Segment operating income for the Commercial reportable segment increased $90.5 million to $194.2 million for the two quarters ended June 29, 2026, from $103.7 million for the two quarters ended June 30, 2025. Segment operating margin rate for the Commercial reportable segment increased to 17.4% for the two quarters ended June 29, 2026, from 14.2% for the two quarters ended June 30, 2025. The primary drivers of these increases were as discussed in the paragraph above.

### Liquidity and Capital Resources

Our principal sources of liquidity have been cash provided by operations, the issuance of debt, and borrowings under our RCF. Our principal uses of cash have been to finance capital expenditures, finance acquisitions, fund working capital requirements, repay debt obligations, and repurchase common stock. We anticipate that financing capital expenditures, financing acquisitions including but not limited to the proposed STG and ILFA acquisitions, funding working capital requirements, servicing debt, and repurchasing common stock will be the principal demands on our cash in the future.

Cash flow provided by operating activities during the first two quarters of 2026 was $118.2 million as compared to cash flow provided by operating activities of $87.1 million in the same period in 2025. The increase in cash flow was primarily due to an increase in net income of $59.3 million partially offset by increased working capital largely driven by the timing of collections.

Net cash used in investing activities during the first two quarters of 2026 was $157.2 million, primarily resulting from the use of $169.2 million for net purchases of property, plant, and equipment and other assets, partially offset by the receipt of $12.0 million of proceeds from the sale of property, plant, and equipment and other assets. Net cash used in investing activities during the first two quarters of 2025 was $123.5 million, primarily resulting from the use of $123.7 million for net purchases of property, plant, and equipment and other assets.

Net cash provided by financing activities during the first two quarters of 2026 was $45.6 million, primarily reflecting proceeds from long-term debt borrowing of $199.2 million, partially offset by repayment of long-term debt borrowings of $143.3 million, repayments of $5.0 million for customer deposits, and $4.7 million for payment of debt issuance costs. Net cash used in financing activities during the first two quarters of 2025 was $19.8 million, reflecting the use of $17.9 million for repurchases of common stock and $1.9 million for the repayment of long-term debt borrowings.

As of June 29, 2026, we had cash and cash equivalents of approximately $507.9 million, of which approximately $185.4 million was held by our foreign subsidiaries, primarily in China, $913.9 million of available borrowing capacity under our RCF, and $5.7 million of available letters of credit under our banking facility. Should we choose to remit cash to the United States from our foreign locations, we may incur tax obligations which would reduce the amount of cash ultimately available to the United States. However, we believe there would be no material tax expenses not previously accrued for the repatriation of this cash.

Our total 2026 capital expenditures are expected to be in the range of $345.0 million to $365.0 million, primarily for capacity expansion to meet market demand.

### Share Repurchases

On May 8, 2025, our Board of Directors authorized the 2025 Repurchase Program, under which we may repurchase up to $100.0 million in value of our common stock from time to time through May 7, 2027. We did not repurchase any shares of our common stock during the quarter ended June 29, 2026. As of June 29, 2026, the remaining amount in value available to be repurchased under the 2025 Repurchase Program was $100.0 million.

### Long-term Debt and Letters of Credit

As of June 29, 2026, we had $973.5 million of outstanding debt, net of discount and issuance costs, composed of $497.8 million of Senior Notes due 2029, $395.7 million under the Amended Term Loan Facility, and $80.0 million under the RCF.

Pursuant to the terms of the Senior Notes due 2029 and the 2026 Credit Agreement (which provides for the Amended Term Loan Facility and the RCF), we are subject to certain affirmative and negative covenants, including limitations on indebtedness, corporate transactions, investments, dispositions, and restricted payments, and with respect to the RCF, various financial covenants, including leverage and interest coverage ratios. As of June 29, 2026, we were in compliance with the covenants under the Senior Notes due 2029 and the 2026 Credit Agreement.

Based on our current level of operations, we believe that cash generated from operations, cash on hand, and cash from the issuance of available term, incremental, and revolving debt will be adequate to meet our currently anticipated capital expenditure, acquisitions, debt service, and working capital needs for the next 12 months. Additional information regarding our indebtedness, including information about the credit available under our debt facilities, interest rates, and other key terms of our outstanding indebtedness, is included in Part I, Item 1, Note 7, *Long‑term Debt and Letters of Credit*, of the Notes to Consolidated Condensed Financial Statements included in this Report.

### Supplier Finance Program Obligations

We have agreements with financial institutions to facilitate payments to certain suppliers. Liabilities associated with these agreements are recorded in accounts payable on the consolidated condensed balance sheets and amounted to $15.3 million and $12.5 million as of June 29, 2026 and December 29, 2025, respectively.

### Contractual Obligations and Commitments

As part of our ongoing operations, we enter into contractual arrangements that obligate us to make future cash payments. These obligations impact our liquidity and capital resource needs. Our estimated future obligations consist of long-term debt obligations, interest on debt obligations, derivative liabilities, purchase obligations, and leases.

A summary of our long-term debt obligations as of June 29, 2026 is included in Part I, Item 1, Note 7, *Long‑term Debt and Letters of Credit*, of the Notes to Consolidated Condensed Financial Statements included in this Report.

Our aggregate interest on debt obligations as of June 29, 2026, amounted to $162.8 million, which is expected to be settled as follows: $45.9 million within 1 year, $89.9 million within 1-3 years, and $27.0 million within 4-5 years. For debt obligations based on variable rates, interest rates used are as of June 29, 2026.

As of June 29, 2026, there were no other material changes outside the ordinary course of business since December 29, 2025 to our contractual obligations and commitments and the related cash requirements.

### Seasonality

We do not consider any material portion of our business to be seasonal. Various factors, however, can affect the distribution of our sales between accounting periods, including the timing of customer orders, the availability of customer funding, product deliveries, and customer acceptance.

### Recently Issued Accounting Standards

For a description of recently adopted and issued accounting standards, including the respective dates of adoption and the expected effects on our results of operations and financial condition, see Part I, Item 1, Note 1, *Nature of Operations and Basis of Presentation*, of the Notes to Consolidated Condensed Financial Statements included in this Report.

## Market risk

As filed, 2,864 characters.

### Foreign Currency Exchange Rate Risks

In connection with the proposed STG acquisition, we expect to become exposed to additional foreign currency risk from the CHF-denominated purchase price and interest related to the planned drawdown under the RCF to finance the proposed STG acquisition, which is expected to close in the third quarter of 2026, subject to the satisfaction of regulatory approvals and other customary closing conditions.

In an effort to economically mitigate these risks, we entered into a deal-contingent forward-starting, fixed-for-fixed USD/CHF cross-currency swap with a major financial institution. As of June 29, 2026, the swap had a net fair value liability of $14.0 million. The terms of the deal-contingent swap were as follows:

*(In thousands, except interest rates)*

|  | As of June 29, 2026 Remaining 2026 | 2027 | 2028 | 2029 | 2030 | Thereafter |
| --- | ---: | ---: | ---: | ---: | ---: | --- |
| USD principal (1) | Pay USD 381,083 | — | — | — | — | Receive USD 381,083 |
| CHF principal (1) | Receive CHF 306,200 | — | — | — | — | Pay CHF 306,200 |
| USD interest (2) | — | Receive 6.00% | Receive 6.00% | Receive 6.00% | Receive 6.00% | Receive 6.00% |
| CHF interest (2) | — | Pay 3.025% | Pay 3.025% | Pay 3.025% | Pay 3.025% | Pay 3.025% |

(1) Effective September 30, 2026 and matures on September 30, 2033.

(2) Settlements commence March 31, 2027 through maturity, settled semiannually each March 31 and September 30.

See Part I, Item 1, Note 1, *Nature of Operations and Basis of Presentation*, of the Notes to Consolidated Condensed Financial Statements in this Report for further information.

### Interest Rate Risks

As of June 29, 2026, 76.5% of our total debt was based on fixed rates. Based on our borrowings as of June 29, 2026, an assumed 100 basis point change in variable rates would cause our annual interest cost to change by $2.3 million.

### Debt Instruments

The fiscal calendar maturities of our debt instruments for the next five years and thereafter were as follows:

*(In thousands, except interest rates)*

|  | As of June 29, 2026 Remaining 2026 | 2027 | 2028 | 2029 | 2030 | Thereafter | Total | Fair Value | Weighted Average Interest Rate |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Variable Rate (1) | $2,000 | $5,000 | $3,000 | $4,000 | $386,000 | $80,000 | $480,000 | $481,000 | 5.36% |
| Fixed Rate | — | — | — | 500,000 | — | — | 500,000 | 481,760 | 4.00 |
| Total | $2,000 | $5,000 | $3,000 | $504,000 | $386,000 | $80,000 | $980,000 | $962,760 |  |

(1) Interest rate swap effectively fixed $250,000 of variable rate debt.

There have been no other material changes to our risks as previously disclosed in Item 7A, *Quantitative and Qualitative Disclosures About Market Risk,* in our Annual Report on Form 10-K for the fiscal year ended December 29, 2025.

## Controls and procedures

As filed, 1,679 characters.

### Evaluation of Disclosure Controls and Procedures

Our management, under the supervision and with the participation of our CEO and CFO, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our CEO and CFO have concluded that, as of June 29, 2026, such disclosure controls and procedures were effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is (1) recorded, processed, summarized, and reported within the time periods specified in the SEC's rules and forms and (2) accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosures.

In designing and evaluating our disclosure controls and procedures, our management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their desired control objectives, and our management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

### Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended June 29, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 2,067 characters.

During the quarter ended June 29, 2026, we identified the following material change to a risk factor that was previously disclosed in Part I, Item 1A, *Risk Factors*, of our Annual Report on Form 10-K for the fiscal year ended December 29, 2025.

### We are subject to risks of currency exchange rate fluctuations.

A portion of our cash, other assets, and liabilities is held in currencies other than the USD. Changes in exchange rates among other currencies and the USD will affect the value of these assets or liabilities and could negatively impact the amount of cash available to fund operations or repay debt. To the extent that we decide to repatriate some portion of these funds to the United States, the actual value transferred could be impacted by movements in exchange rates. Additionally, we expect to have revenues, expenses, and costs denominated in currencies other than the USD, which include but are not limited to the RMB, the MYR, the CHF, and the Euro. Fluctuations in the exchange rates between the USD and the RMB, the MYR, the CHF, the Euro, or any other currency where we are exposed to foreign currency risk and do not hedge to manage such risk could result in increases in our expenses or decreases in our revenues, which could negatively impact our business, financial condition, and results of operations. In connection with the proposed STG acquisition, we entered into a deal-contingent USD/CHF cross-currency swap, as disclosed in more detail above. Significant inflation or disproportionate changes in foreign exchange rates could occur from general economic conditions, acts of war or terrorism, changes in governmental monetary or tax policy, or changes in local interest rates. Further, China’s government imposes controls over the convertibility of RMB into foreign currencies, which subjects us to further currency exchange risk.

There have been no other material changes in our risk factors as previously disclosed in Part I, Item 1A, *Risk Factors*, of our Annual Report on Form 10-K for the fiscal year ended December 29, 2025.

Filed Aug 5, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-335107. Last ingested by Listed: Nov 14, 2026, 14:47 ET. No prices; not investment advice.
